Mesoblast Limited (MESO) Financials

MESO Assets vs Liabilities
DateAssetsLiabilities
Dec. 31, 2025 782.3 million 207.6 million
Sept. 30, 2025 ? ?
June 30, 2025 784.7 million 187.2 million
March 31, 2025 784.7 million 187.2 million

MESO Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
Dec. 31, 2025 -15.7 million ?
Sept. 30, 2025 -15.3 million ?
June 30, 2025 -14.9 million 3.5 million
March 31, 2025 -12.8 million ?

MESO Net Income

No data available :(

MESO Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
Dec. 31, 2025 129.6 million 66.0 million 8.3 million
Sept. 30, 2025 - - -
June 30, 2025 161.2 million 71.3 million 6.3 million
March 31, 2025 161.6 million 71.3 million 6.3 million

MESO Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
Dec. 31, 2025 1.3 billion
Sept. 30, 2025 ?
June 30, 2025 127.3 million
March 31, 2025 127.3 million

MESO Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
Dec. 31, 2025 133000 - - -
Sept. 30, 2025 349000 - - -
June 30, 2025 287000 7.1 million 11.1 million 2.5 million
March 31, 2025 125000 7.1 million 11.1 million 2.5 million

MESO Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
Dec. 31, 2025 - -
Sept. 30, 2025 - -
June 30, 2025 7.0 million 23.2 million
March 31, 2025 7.0 million 23.2 million

MESO

Price: $13.93

52 week price:
9.88
21.50

Earnings Per Share: -0.85 USD

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Country: Australia

Volume: 45251

Ebitda: -19.5 million

Market Capitalization: 1.8 billion

Links: